Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ezra, D
Right arrow Articles by Rosenthal, T
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ezra, D
Right arrow Articles by Rosenthal, T

Chest, Vol 77, 662-665, Copyright © 1980 by American College of Chest Physicians

ARTICLES

Atenolol in hypertension: a cardioselective drug

D Ezra, M Molho and T Rosenthal

The efficary of atenolol given one daily was assessed in 41 otherwise healthy hypertensive patients over a period of six months. Twelve patients whose blood pressure was not well-controlled on methyldopa and chlorthalidone and 11 patients who were treated previously with other beta-blockers all benefited from atenolol which appeared to be effective and well-tollerated. Ten patients complained of fatigue not necessarily related to a drop in blood pressure, and two of headache. Respiratory functions were assessed in a double blind trial on 30 patients. No significant changes in any of the expiratory flow rates were recorded after three months of continuous treatment with atenolol in either smokers or nonsmokers.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the American College of Chest Physicians.